Employment-Based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 2
Recruitment status was Active, not recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine whether long-term exposure to the Therapeuitc Workplace intervention could sustain drug abstinence over an extended period of time in heroin- and cocaine-dependent, unemployed, treatment-resistant young mothers.
| Condition | Intervention |
|---|---|
|
Behavior Therapy Cocaine Abuse Cocaine Dependence Contingency Management Heroin Dependence Methadone Opioid Dependence |
Behavioral: Contingency management |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | A Therapeutic Workplace for Drug Abusers |
- Percentage of urine samples at the assessments that were negative for cocaine, opiates, and opiates and cocaine
- HIV risk behaviors
- Percentage of participants employed each month
- Number of days employed each month
- Percentage of participants to self-report abstinence at all time points
| Estimated Enrollment: | 40 |
| Study Start Date: | October 1996 |
| Estimated Study Completion Date: | January 2006 |
The current study is a continuation of the research into the development and evaluation of a novel treatment designed to address the chronic, persistent nature of drug addiction. This treatment, called the Therapeutic Workplace, integrates abstinence reinforcement contingencies of proven efficacy into a model supported work program. Participants were paid to work or to train in the Therapeutic Workplace but had to provide drug-free urine samples to gain daily access. Forty participants were randomly assigned to a Therapeutic Workplace or usual care control group. Therapeutic Workplace participants could work for about 5 years. This study reports the effects of the intervention over a follow-up period of 8 years after treatment initiation.
Eligibility| Ages Eligible for Study: | 18 Years to 50 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- When originally enrolled in the study, participants were at least 18 years old, unemployed, and methadone maintenance patients of the Center for Addiction and Pregnancy (CAP) who continued to use opiates or cocaine during CAP treatment.
Exclusion Criteria:
- Participants were excluded if they were at risk for suicide at the time of intake or if they had serious psychiatric illness (e.g., schizophrenia).
Contacts and Locations| United States, Maryland | |
| The Center for Learning and Health | |
| Baltimore, Maryland, United States, 21224 | |
| Principal Investigator: | Kenneth Silverman, Ph.D. | Johns Hopkins University |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00249457 History of Changes |
| Other Study ID Numbers: | NIDA-13107-2, R01-13107-2 |
| Study First Received: | November 3, 2005 |
| Last Updated: | November 3, 2005 |
| Health Authority: | United States: Federal Government |
Additional relevant MeSH terms:
|
Cocaine-Related Disorders Heroin Dependence Opioid-Related Disorders Substance-Related Disorders Mental Disorders |
ClinicalTrials.gov processed this record on May 23, 2013